Last reviewed · How we verify

Valproate, Levocarnitine — Competitive Intelligence Brief

Valproate, Levocarnitine (Valproate, Levocarnitine) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Anticonvulsant, Antimanic. Area: Neurology, Psychiatry.

phase 3 Anticonvulsant, Antimanic Neurology, Psychiatry Small molecule Live · refreshed every 30 min

Target snapshot

Valproate, Levocarnitine (Valproate, Levocarnitine) — All India Institute of Medical Sciences. Valproate is a mood stabilizer that works by reducing the activity of certain brain chemicals, while Levocarnitine is involved in energy production within cells.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Valproate, Levocarnitine TARGET Valproate, Levocarnitine All India Institute of Medical Sciences phase 3 Anticonvulsant, Antimanic

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Anticonvulsant, Antimanic class)

  1. All India Institute of Medical Sciences · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Valproate, Levocarnitine — Competitive Intelligence Brief. https://druglandscape.com/ci/valproate-levocarnitine. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators: